Skip to content

VRXAW

Veraxa Biotech Holding AG

NASDAQ · Healthcare · Biotechnology · CH

$0.03
+0.00%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
—

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
—
Price / sales
—
Price / cash flow
—

Enterprise value

Enterprise value
$804.5K
EV / sales
—
EV / EBITDA
—
EV / EBIT
—
Market cap
$804.5K

Trailing, forward and enterprise-value multiples for the requested listing